Clinical Trials Logo

Clinical Trial Summary

Clarify the incidence of functional impairments in cured COVID-19 patients and identify influencing factors. Build a multi-omics database for COVID-19 patients in the recovery period to elucidate the biological biomarkers and targets associated with functional impairments. Comprehensive exploration of the long-term prognosis, complications, sequelae, and risk factors of COVID-19 patients after Omicron infection, as well as their immune characteristics. Compare the impact of different strains of the COVID-19 virus on prognosis and immune response. Develop comprehensive rehabilitation intervention strategies for COVID-19 patients with functional impairments and evaluate the impact of different intervention methods on their prognosis. Based on clinical data, multi-omics data, and precise rehabilitation assessment data, construct predictive models for prognosis and rehabilitation effectiveness in COVID-19, providing scientific evidence for the implementation of effective COVID-19 rehabilitation measures.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06349720
Study type Observational
Source Capital Medical University
Contact Zhaohui Tong, Doctor
Phone +86 139 1093 0309
Email 13910930309@163.com
Status Recruiting
Phase
Start date June 7, 2023
Completion date June 7, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04592835 - To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003 Phase 1
Not yet recruiting NCT05083104 - Assessment of the Natural Anticoagulant Profile in Patients With COVID-19
Completed NCT05162534 - Independent Predictors on Clinical Outcomes in SARS-CoV2 Patients
Completed NCT04853979 - Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure N/A
Completed NCT05369676 - To Evaluate SSD8432/ Ritonavir in Adults With COVID-19 Phase 1/Phase 2
Completed NCT05901337 - Cupping Therapy on Immune System in Post Covid -19 N/A
Completed NCT04407130 - Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection. Phase 2
Not yet recruiting NCT04427878 - Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients? N/A
Terminated NCT04541485 - To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines) Phase 1
Withdrawn NCT04374903 - Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients N/A